CervoMed Inc. — Director's Dealing 2014

Jun 10, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RestorGenex Corp (RESX)
CIK: 0001053691
Period of Report: 2014-06-06

Reporting Person: BARER SOL J (Director, Chairman of the Board, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-06-06	Common Stock	C	270616	$2	Acquired	46103949	Direct
2014-06-06	Common Stock	C	78473	$2	Acquired	46182422	Direct
2014-06-06	Common Stock	C	76755	$2	Acquired	46259177	Direct
2014-06-06	Common Stock	C	126894	$2	Acquired	46386071	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-06-06	Secured Convertible Promissory Note dated 8/9/13	$	C	270606	Disposed		Common Stock (270616)	Direct
2014-06-06	Warrant	$2	A	202962	Acquired	2018-06-06	Common Stock (202962)	Direct
2014-06-06	Secured Convertible Promissory Note dated 12/19/13	$	C	78473	Disposed		Common Stock (78473)	Direct
2014-06-06	Secured Convertible Promissory Note dated 2/4/14	$	C	76755	Disposed		Common Stock (76755)	Direct
2014-06-06	Warrant	$2	A	57566	Acquired	2018-06-06	Common Stock (57566)	Direct
2014-06-06	Secured Convertible Promissory Note dated 3/19/14	$	C	126894	Disposed		Common Stock (126894)	Direct
2014-06-06	Warrant	$2	A	95170	Acquired	2018-06-06	Common Stock (95170)	Direct

Footnotes

F1: Conversion of Secured Convertible Promissory Note dated August 9, 2013 in compliance with terms of such note whereby principal and interest ($541,233) were to be converted into common stock at 50% of the purchase price and warrants at 150% upon a financing by the Issuer. The Issuer's May financing sold the stock at $4.00 per share with 30% warrant coverage.

F2: Conversion of Secured Convertible Promissory Note dated December 19, 2013 in compliance with terms of such note whereby principal and interest ($156,945) were to be converted into common stock at 50% of the purchase price upon a financing by the Issuer. The Issuer's May financing sold the stock at $4.00 per share

F3: Conversion of Secured Convertible Promissory Note dated February 4, 2014 in compliance with terms of such note whereby principal and interest ($153,510) were to be converted into common stock at 50% of the purchase price and warrants at 150% upon a financing by the Issuer. The Issuer's May financing sold the stock at $4.00 per share with 30% warrant coverage.

F4: Conversion of Secured Convertible Promissory Note dated March 19, 2014 in compliance with terms of such note whereby principal and interest ($253,788) were to be converted into common stock at 50% of the purchase price and warrants at 150% upon a financing by the Issuer. The Issuer's May financing sold the stock at $4.00 per share with 30% warrant coverage.